Annual ROA
-33.23%
-5.84%-21.32%
31 December 2023
Summary:
Theriva Biologics annual return on assets is currently -33.23%, with the most recent change of -5.84% (-21.32%) on 31 December 2023. During the last 3 years, it has risen by +86.19% (+72.17%). TOVX annual ROA is now -63.86% below its all-time high of -20.28%, reached on 31 December 2021.TOVX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-57.26%
-14.41%-33.63%
01 September 2024
Summary:
Theriva Biologics quarterly return on assets is currently -57.26%, with the most recent change of -14.41% (-33.63%) on 01 September 2024. Over the past year, it has dropped by -28.30% (-97.72%). TOVX quarterly ROA is now -472.60% below its all-time high of -10.00%, reached on 01 March 1993.TOVX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -21.3% | -97.7% |
3 y3 years | +72.2% | -202.8% |
5 y5 years | +62.6% | +17.1% |
TOVX ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -63.9% | +72.2% | -202.8% | at low |
5 y | 5 years | -63.9% | +72.2% | -209.0% | +47.1% |
alltime | all time | -63.9% | +96.8% | -472.6% | +96.5% |
Theriva Biologics ROA History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | -57.26%(+33.6%) |
June 2024 | - | -42.85%(+30.0%) |
Mar 2024 | - | -32.97%(+12.3%) |
Dec 2023 | -33.23%(+21.3%) | -29.35%(+1.3%) |
Sept 2023 | - | -28.96%(+0.3%) |
June 2023 | - | -28.88%(+9.2%) |
Mar 2023 | - | -26.45%(+8.1%) |
Dec 2022 | -27.39%(+35.1%) | -24.46%(+5.9%) |
Sept 2022 | - | -23.10%(+5.9%) |
June 2022 | - | -21.82%(+6.2%) |
Mar 2022 | - | -20.54%(+8.6%) |
Dec 2021 | -20.28%(-83.0%) | - |
Dec 2021 | - | -18.91%(+2.1%) |
Sept 2021 | - | -18.53%(-19.9%) |
June 2021 | - | -23.13%(-37.3%) |
Mar 2021 | - | -36.89%(-65.9%) |
Dec 2020 | -119.42%(+34.5%) | -108.33%(+12.3%) |
Sept 2020 | - | -96.49%(+1.8%) |
June 2020 | - | -94.82%(+18.7%) |
Mar 2020 | - | -79.90%(+15.7%) |
Dec 2019 | -88.79%(+100.2%) | -69.08%(+14.3%) |
Sept 2019 | - | -60.43%(-0.4%) |
June 2019 | - | -60.70%(-20.8%) |
Mar 2019 | - | -76.66%(-11.4%) |
Dec 2018 | -44.35%(-44.9%) | -86.48%(+48.7%) |
Sept 2018 | - | -58.14%(-37.2%) |
June 2018 | - | -92.60%(+11.2%) |
Mar 2018 | - | -83.29%(+3.7%) |
Dec 2017 | -80.55%(-33.5%) | -80.31%(-22.0%) |
Sept 2017 | - | -102.97%(-7.3%) |
June 2017 | - | -111.08%(-6.6%) |
Mar 2017 | - | -118.87%(-23.9%) |
Dec 2016 | -121.14%(-14.6%) | -156.14%(-14.9%) |
Sept 2016 | - | -183.51%(+50.6%) |
June 2016 | - | -121.84%(-22.0%) |
Mar 2016 | - | -156.30%(-11.5%) |
Dec 2015 | -141.80%(+37.2%) | -176.66%(-1.7%) |
Sept 2015 | - | -179.71%(-40.6%) |
June 2015 | - | -302.37%(+25.2%) |
Mar 2015 | - | -241.45%(+39.4%) |
Dec 2014 | -103.34%(+36.4%) | -173.15%(+5.7%) |
Sept 2014 | - | -163.74%(+15.3%) |
June 2014 | - | -142.00%(+15.6%) |
Mar 2014 | - | -122.79%(+11.0%) |
Dec 2013 | -75.76%(-40.4%) | -110.66%(-42.8%) |
Sept 2013 | - | -193.43%(+4.8%) |
June 2013 | - | -184.63%(-2.6%) |
Mar 2013 | - | -189.60%(-3.2%) |
Dec 2012 | -127.15%(+16.7%) | -195.94%(+72.9%) |
Sept 2012 | - | -113.33%(+22.3%) |
June 2012 | - | -92.68%(+10.0%) |
Mar 2012 | - | -84.22%(-15.0%) |
Dec 2011 | -109.00%(+160.8%) | -99.14%(+25.4%) |
Sept 2011 | - | -79.08%(-7.8%) |
June 2011 | - | -85.73%(+56.6%) |
Mar 2011 | - | -54.75%(+32.3%) |
Dec 2010 | -41.80% | -41.39%(-8.4%) |
Sept 2010 | - | -45.17%(+10.9%) |
June 2010 | - | -40.72%(-45.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | -74.58%(+15.8%) |
Dec 2009 | -65.12%(-5.0%) | -64.43%(+20.7%) |
Sept 2009 | - | -53.39%(-7.8%) |
June 2009 | - | -57.93%(-5.7%) |
Mar 2009 | - | -61.46%(-15.6%) |
Dec 2008 | -68.56%(-9.4%) | -72.81%(-20.8%) |
Sept 2008 | - | -91.90%(-2.3%) |
June 2008 | - | -94.09%(+4.1%) |
Mar 2008 | - | -90.35%(+5.5%) |
Dec 2007 | -75.66%(+28.8%) | -85.66%(-14.5%) |
Sept 2007 | - | -100.23%(-6.7%) |
June 2007 | - | -107.48%(-19.4%) |
Mar 2007 | - | -133.42%(-10.4%) |
Dec 2006 | -58.75%(-36.0%) | -148.96%(-71.4%) |
Sept 2006 | - | -520.21%(+51.8%) |
June 2006 | - | -342.61%(+26.5%) |
Mar 2006 | - | -270.76%(-22.0%) |
Dec 2005 | -91.78%(-81.0%) | - |
Mar 2003 | - | -347.25%(-19.6%) |
Dec 2002 | -482.65%(+91.1%) | -431.87%(-5.0%) |
Sept 2002 | - | -454.42%(+2.2%) |
June 2002 | - | -444.52%(+18.8%) |
Mar 2002 | - | -374.33%(-28.0%) |
Dec 2001 | -252.54%(+130.0%) | -519.89%(+16.9%) |
Sept 2001 | - | -444.92%(+11.9%) |
June 2001 | - | -397.51%(+21.2%) |
Mar 2001 | - | -328.11%(+176.3%) |
Dec 2000 | -109.78%(-75.0%) | -118.74%(-72.2%) |
Sept 2000 | - | -427.20%(-9.1%) |
June 2000 | - | -470.04%(-9.3%) |
Mar 2000 | - | -518.47%(-19.1%) |
Dec 1999 | -439.50%(-57.9%) | -640.92%(+195.3%) |
Sept 1999 | - | -217.05%(+23.1%) |
June 1999 | - | -176.27%(-70.8%) |
Mar 1999 | - | -603.72%(-16.5%) |
Dec 1998 | -1044.20%(+92.4%) | -723.03%(-14.9%) |
Sept 1998 | - | -849.56%(-16.8%) |
June 1998 | - | -1021.51%(+52.7%) |
Mar 1998 | - | -669.12%(+32.4%) |
Dec 1997 | -542.86%(+93.9%) | -505.32%(+33.1%) |
Sept 1997 | - | -379.70%(+37.2%) |
June 1997 | - | -276.84%(+30.6%) |
Mar 1997 | - | -212.04%(+6.3%) |
Dec 1996 | -280.00%(-50.8%) | -199.44%(+4.3%) |
Sept 1996 | - | -191.26%(-12.7%) |
June 1996 | - | -218.98%(-24.2%) |
Mar 1996 | - | -288.75%(-23.3%) |
Dec 1995 | -569.23%(-0.6%) | -376.27%(-0.6%) |
Sept 1995 | - | -378.38%(-76.7%) |
June 1995 | - | -1625.00%(+4.8%) |
Mar 1995 | - | -1550.00%(+585.6%) |
Dec 1994 | -572.73%(+164.3%) | -226.09%(+38.9%) |
Sept 1994 | - | -162.77%(+14.6%) |
June 1994 | - | -142.03%(+40.5%) |
Mar 1994 | - | -101.06%(-8.7%) |
Dec 1993 | -216.67% | -110.64%(+89.0%) |
Sept 1993 | - | -58.54%(+175.1%) |
June 1993 | - | -21.28%(+112.8%) |
Mar 1993 | - | -10.00% |
FAQ
- What is Theriva Biologics annual return on assets?
- What is the all time high annual ROA for Theriva Biologics?
- What is Theriva Biologics annual ROA year-on-year change?
- What is Theriva Biologics quarterly return on assets?
- What is the all time high quarterly ROA for Theriva Biologics?
- What is Theriva Biologics quarterly ROA year-on-year change?
What is Theriva Biologics annual return on assets?
The current annual ROA of TOVX is -33.23%
What is the all time high annual ROA for Theriva Biologics?
Theriva Biologics all-time high annual return on assets is -20.28%
What is Theriva Biologics annual ROA year-on-year change?
Over the past year, TOVX annual return on assets has changed by -5.84% (-21.32%)
What is Theriva Biologics quarterly return on assets?
The current quarterly ROA of TOVX is -57.26%
What is the all time high quarterly ROA for Theriva Biologics?
Theriva Biologics all-time high quarterly return on assets is -10.00%
What is Theriva Biologics quarterly ROA year-on-year change?
Over the past year, TOVX quarterly return on assets has changed by -28.30% (-97.72%)